Secondary
Sage Therapeutics, Inc.
Sage Therapeutics is a clinical-stage biopharmaceutical company committed to developing novel medicines to transform the lives of patients with life-altering central nervous system (CNS) disorders.
Symbol
SAGE
Last Closing Price
$88.25
Effective Date
November 15, 2017
Underwriters
J.P. Morgan, Goldman Sachs, Morgan Stanley
To view the prospectus for Sage Therapeutics, Inc., or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277